1. Home
  2. ARCT vs TCI Comparison

ARCT vs TCI Comparison

Compare ARCT & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • TCI
  • Stock Information
  • Founded
  • ARCT 2013
  • TCI 1983
  • Country
  • ARCT United States
  • TCI United States
  • Employees
  • ARCT N/A
  • TCI N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • TCI Real Estate
  • Sector
  • ARCT Health Care
  • TCI Finance
  • Exchange
  • ARCT Nasdaq
  • TCI Nasdaq
  • Market Cap
  • ARCT 320.8M
  • TCI 357.8M
  • IPO Year
  • ARCT N/A
  • TCI N/A
  • Fundamental
  • Price
  • ARCT $17.32
  • TCI $46.96
  • Analyst Decision
  • ARCT Strong Buy
  • TCI
  • Analyst Count
  • ARCT 10
  • TCI 0
  • Target Price
  • ARCT $50.88
  • TCI N/A
  • AVG Volume (30 Days)
  • ARCT 536.4K
  • TCI 1.6K
  • Earning Date
  • ARCT 11-06-2025
  • TCI 11-06-2025
  • Dividend Yield
  • ARCT N/A
  • TCI N/A
  • EPS Growth
  • ARCT N/A
  • TCI 11.20
  • EPS
  • ARCT N/A
  • TCI 0.76
  • Revenue
  • ARCT $122,122,000.00
  • TCI $47,730,000.00
  • Revenue This Year
  • ARCT N/A
  • TCI N/A
  • Revenue Next Year
  • ARCT $31.09
  • TCI N/A
  • P/E Ratio
  • ARCT N/A
  • TCI $61.45
  • Revenue Growth
  • ARCT N/A
  • TCI N/A
  • 52 Week Low
  • ARCT $8.04
  • TCI $25.50
  • 52 Week High
  • ARCT $25.88
  • TCI $48.00
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 54.49
  • TCI 57.33
  • Support Level
  • ARCT $17.38
  • TCI $45.43
  • Resistance Level
  • ARCT $18.69
  • TCI $47.00
  • Average True Range (ATR)
  • ARCT 1.00
  • TCI 0.44
  • MACD
  • ARCT -0.11
  • TCI -0.16
  • Stochastic Oscillator
  • ARCT 44.23
  • TCI 61.94

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

Share on Social Networks: